Robert Gregg joins OraSure
This article was originally published in RAJ Devices
US oral fluid diagnostics specialist OraSure Technologies has appointed Robert Gregg vice president of regulatory affairs and quality assurance. Dr Gregg will be responsible for the Bethlehem, Philadelphia-based firm’s regulatory, quality assurance and clinical affairs issues. He has over 25 years of experience in the medical devices and diagnostics sector, having worked at Roche Diagnostics, Johnson & Johnson and the US Food and Drug Administration. Most recently, Dr Gregg was vice president of corporate regulatory affairs and quality systems at Perkin Elmer, which he joined in 2004.
You may also be interested in...
Israel is well-known as a medtech hot-spot, with a focus on academic research and strong government support helping the country punch well above its weight when it comes to innovative devices.
St Jude Medical had a heavy focus on its intravascular imaging offering at this year’s EuroPCR meeting, presenting data supporting its optical coherence tomography (OCT) technology. OCT provides intravascular images to help assess culprit lesions, which can improve stent selection and deployment, according to St Jude.
A big topic at this year’s EuroPCR, held in Paris on 19-22 May, was drug-coated balloons (DCBs). One of the leaders in the field, Medtronic, presented positive data from two studies of its IN.PACT Admiral balloon, which could support an expanded indication for the device.